Abstract: Objective To investigate the role of CCAT enhancer binding protein α (C/EBP-α) in autophagy of hepatic stellate cells (HSCs). Methods C/EBP-α Lentiviral vector was constructed. HSC-T6 was treated with C/ EBP-α Lentiviral vector, autophagy activator Rapamycin or C/EBP-α Lentiviral vector plus Rapamycin. Autophagyrelated protein LC3 and C/EBP-α were detected with Western blotting. Results Treatment of Lenti-C/EBP-α induced decreased expression of LC3 in HSC-T6 while Rapamycin upregulated levels of LC3 and downregulated expression of C/EBP-α.Co-incubation of Lenti-C/EBP-α and Rapamycin suggested that C/EBP-α expression was increased and LC3 expression was decreased when compared with Rapamycin only group. Conclusion C/EBP-α inhibits activation of HSC-T6 inhibition of autophagy, which may be a novel approach for anti-hepatic fibrosis.